Top Vaccines companies in Switzerland by Gross Profit
Switzerland
# |
Name |
Gross Profit |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 4.56 B
|
Dec. 31, 2023 | USD 48.28 | 3.35% |
|
Switzerland |
|
| 2 |
USD 155.40 M
|
Dec. 31, 2023 | USD 45.08 | 2.29% |
|
Switzerland |
|
| 3 |
USD 67.03 M
|
Dec. 31, 2023 | USD 1.68 | -2.33% |
|
Switzerland |
|
| 4 |
USD 5.12 M
|
Dec. 31, 2023 | USD 26.45 | -1.05% |
|
Switzerland |
|
| 5 |
USD -13.16 K
|
Dec. 31, 2023 | USD 45.99 | -2.40% |
|
Switzerland |
|
| 6 |
USD -47.28 M
|
Dec. 31, 2023 | USD 2.75 | 1.85% |
|
Switzerland |
|
| 7 |
USD -48.47 M
|
Dec. 31, 2023 | USD 4.99 | 1.08% |
|
Switzerland |
Frequently Asked Questions
-
Which Vaccines company in Switzerland has the highest Gross Profit ?
The Vaccines company in Switzerland with the highest Gross Profit is Sandoz Group AG (Swiss Stock Exchange: SDZ.SW) at USD 4.56 B.
-
Which Vaccines company in Switzerland has the lowest Gross Profit ?
The Vaccines company in Switzerland with the lowest Gross Profit is Molecular Partners AG (Swiss Stock Exchange: MOLN.SW) at USD -48.47 M.
-
What are the top 10 Vaccines companies in Switzerland by Gross Profit ?
The top 10 Vaccines companies in Switzerland by Gross Profit are Sandoz Group AG, Basilea Pharmaceutica AG, ADC Therapeutics SA, PolyPeptide Group AG, MoonLake Immunotherapeutics, AC Immune SA and Molecular Partners AG.
-
What are the bottom 10 Vaccines companies in Switzerland by Gross Profit ?
The bottom 10 Vaccines companies in Switzerland by Gross Profit are Molecular Partners AG, AC Immune SA, MoonLake Immunotherapeutics, PolyPeptide Group AG, ADC Therapeutics SA, Basilea Pharmaceutica AG and Sandoz Group AG.
